1 drug(s) with this reaction
344 total reports
Product Dose Omission Issue has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 344 adverse event reports mention product dose omission issue in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with product dose omission issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have product dose omission issue listed in their FDA adverse event reports, sorted by report count:
In addition to product dose omission issue, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have product dose omission issue listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 344 reports of product dose omission issue across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.